- 70% of CPG brands are losing the 'race to shelf' due to slow execution.
- 62% of R&D time is spent on rework and troubleshooting existing formulas.
- 19% of organizations have successfully embedded AI into daily R&D workflows.
Experts agree that CPG brands must overhaul their innovation systems to keep pace with rapidly evolving consumer demands, as current structures are failing to execute ideas efficiently.
CPG's Ticking Clock: Why 70% of Brands Are Losing the Race to Shelf
SAN FRANCISCO, CA – June 22, 2026 – The consumer packaged goods (CPG) industry is facing a stark reality: despite being flush with ideas, the majority of brands are failing to get them to market fast enough. A new report from innovation platform Turing Labs reveals that a staggering 70% of CPG companies are consistently losing the "race to shelf," watching competitors launch first in the very trend spaces they are actively pursuing.
The report, based on a Q1 2026 survey of 290 senior leaders across U.S. and European food and beverage giants, points not to a lack of creativity, but to a fundamental, structural breakdown in execution. “CPG companies do not have an ideas problem. They have an execution-speed problem,” stated Manmit Shrimali, CEO and Founder of Turing Labs. This gap is widening at a critical moment, as consumer preferences—reshaped by everything from new pharmaceuticals to clean-label demands—are shifting faster than at any point in the last two decades. The findings suggest that the industry's traditional innovation engine is sputtering, unable to keep pace with a rapidly accelerating market.
The Anatomy of a Slowdown
The report paints a damning picture of internal R&D departments bogged down by inefficiency. A remarkable 62% of R&D time is reportedly absorbed by rework and troubleshooting existing formulas, leaving scant resources for the offensive, forward-looking innovation required to win. This creates a vicious cycle known as the "reformulation trap," where over half of all new products require costly and time-consuming reformulation within just 12 months of launch due to unforeseen margin pressures or ingredient availability issues.
"We spend more time fixing what's already on the shelf than creating what comes next," admitted one senior R&D director at a major food conglomerate. "We're in a constant state of defense, reacting to supply chain shocks or regulatory changes, while smaller, faster brands are defining the next big thing."
These internal bottlenecks are dangerously compounded by powerful external forces. The rapid adoption of GLP-1 weight-loss drugs, now used by an estimated 16 million U.S. adults, is fundamentally altering consumer appetites and creating demand for entirely new product categories focused on high protein, low sugar, and smaller portions. Simultaneously, the "clean label" movement continues to gain momentum, with consumers and regulators alike demanding greater transparency and the removal of ingredients like Red Dye No. 3. These pressures force R&D teams into yet more reactive reformulations, further draining their capacity for genuine innovation. All the while, nimble challenger brands, unburdened by legacy systems and complex approval hierarchies, are capitalizing on these trends in record time.
The AI Paradox: Big Investments, Little Impact
For years, artificial intelligence has been touted as the silver bullet for CPG's innovation woes. Yet, the Turing Labs report uncovers a troubling paradox: while AI adoption is up, its business impact is strikingly absent. According to the survey, more than six in ten internal AI initiatives have delivered no measurable business impact, and a mere 19% of organizations have successfully embedded AI into their daily R&D workflows.
The core of the problem lies in a mismatch between technology and application. Many companies have attempted to apply general-purpose AI tools to the highly specialized, scientific discipline of product formulation. This often results in outputs that are too vague or scientifically unsound for practical use, requiring extensive manual validation that negates any potential time savings. "We piloted a generative AI tool to suggest new flavor combinations," an innovation leader at a beverage company shared. "It gave us concepts, but it couldn't account for ingredient interactions, stability, or our cost structure. It created more work for our formulators, not less."
Furthermore, successful case studies from companies like Mondelēz International, Nestlé, and Procter & Gamble reveal a different path. These leaders aren't just using AI to speed up existing, broken processes. They are fundamentally redesigning their innovation workflows around it. Nestlé, for instance, compressed its product ideation timeline from six months to six weeks by developing an enterprise-wide AI platform that connects real-time market trends directly to R&D. P&G has built a proprietary machine learning platform that makes its data scientists ten times faster. These successes highlight that AI's value is unlocked not as a standalone tool, but as the integrated core of a new, data-driven innovation strategy.
Rebuilding the Innovation Engine
The industry's execution-speed problem demands more than incremental fixes; it requires a complete overhaul of the innovation engine itself. This is where a new category of purpose-built platforms, like the one offered by Turing Labs, comes into focus. By digitizing decades of formulation expertise and leveraging domain-specific AI, these systems aim to bridge the gap between a great idea and a shelf-winning product.
Unlike generic AI, these platforms are designed to understand the complex, multi-variable world of CPG product development—from ingredient chemistry and regulatory constraints to manufacturing feasibility and commercial KPIs. They allow R&D teams to run thousands of virtual experiments, accurately predicting how a new formula will perform on taste, texture, cost, and shelf life before a single physical batch is mixed. This predictive capability has the potential to slash the rework and troubleshooting that currently consumes over 60% of R&D capacity.
Backed by prominent investors like Y Combinator and Insight Partners, Turing Labs has been deploying its system inside some of the world's top 20 CPG enterprises for six years. The goal is to create a single, unified "innovation system" that guides a product from initial concept to commercialization, with AI providing intelligence at every step. This approach directly tackles the issue of siloed data and disconnected legacy systems that plague most large organizations. As Manmit Shrimali noted, winning in today's market requires "the winning mindset, culture to take risks, and systems that turn the right ideas into shelf-winning products at scale." For the 70% of CPG brands currently falling behind, rebuilding that system is no longer an option, but an urgent strategic imperative.
